Related Experiment Video
Updated: May 15, 2026
03:23
Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Targeting eosinophils in allergy, inflammation and beyond.
Patricia C Fulkerson1, Marc E Rothenberg
1Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229, USA. Patricia.Fulkerson@cchmc.org
Nature Reviews. Drug Discovery
|January 22, 2013
Summary
New therapies targeting eosinophils show promise for treating inflammatory diseases like asthma and allergies. These eosinophil-targeted treatments are advancing, offering new hope for personalized medicine approaches.
Area of Science:
- Immunology
- Pharmacology
- Medical Science
Background:
- Eosinophils play a key role in immune and inflammatory responses.
- Eosinophil accumulation is linked to inflammatory, infectious, atopic, autoimmune, and malignant diseases.
- Understanding eosinophil function is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent advancements in eosinophil-targeted therapies.
- To highlight the potential of these therapies in treating various disorders.
- To explore strategies for personalized medicine in managing eosinophilic conditions.
Main Methods:
- Review of current literature on eosinophil-targeted therapeutic agents.
- Analysis of clinical trial data for first-generation eosinophil therapies.
- Exploration of personalized medicine approaches for eosinophilic disorders.
Main Results:
- First-generation eosinophil-targeted therapies are entering clinical testing with encouraging outcomes.
- These therapies aim to block key steps in eosinophil development, migration, and activation.
- Recent advances provide insights into the multifaceted role of eosinophils in disease.
Conclusions:
- Eosinophil-targeted therapies represent a promising new avenue for disease treatment.
- Personalized medicine strategies can optimize the use of these therapies for eosinophilic disorders.
- Further research and clinical trials are essential to fully realize the potential of eosinophil-targeted treatments.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
02:06Allergic Reactions
Overview
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: